|
HS Code |
539464 |
As an accredited 5-Bromo-2-(Trifluoromethyl)Pyrimidine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 5-Bromo-2-(Trifluoromethyl)Pyrimidine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
5-Bromo-2-(Trifluoromethyl)Pyrimidine, known through its systematic structure as a brominated pyrimidine derivative, deserves more attention than it usually receives outside specialty chemical circles. In laboratories and industry, this compound often gets labeled with an identification such as CAS 252919-47-4, though the real story is about its practical roles. The model reflects a robust scaffold: a pyrimidine ring split by a trifluoromethyl group at position 2 and a bromine at position 5. This geometry creates a standout pattern, one that skilled synthetic chemists lean on for selective transformations. That’s not just a point about its formula; it’s a nod to the deep bench of methods that become possible with carefully placed electron-withdrawing groups.
This structure means a lot to folks like me who have spent time mixing reagents and running columns late into the night. The presence of both bromine and the trifluoromethyl group changes how the pyrimidine handles nucleophiles and electrophiles alike. I’ve seen how the electron-poor nature of the ring can direct cross-coupling reactions—especially in palladium-catalyzed Suzuki or Buchwald–Hartwig couplings. Once you’ve used a compound like this as a building block, it’s clear why you keep a few grams on the shelf if you’re working up anything involving heterocycles or wanting to build out chemical libraries.
5-Bromo-2-(Trifluoromethyl)Pyrimidine comes as a pale solid—sometimes almost white, sometimes off-white, depending on lab conditions and supplier. Purity levels typically reach 97% or higher from established sources. Solubility trends toward common organic solvents like dichloromethane, acetonitrile, or tetrahydrofuran. Moisture sensitivity crops up as a talking point sometimes, usually more relevant when you need the cleanest result at scale. I’ve worked with lots of aromatic heterocyclic systems, and this one consistently dissolves well in reaction media—much less hassle than many similar compounds.
Melting points hover in ranges practical for weighing on an open bench without visible degradation. You don’t get pungent odors or volatility, which means fewer headaches and routine use without special containment. Analytical workup shows predictable values—NMR gives sharp, split peaks for the trifluoromethyl group, and bromine coupling shows up as expected. In chromatography, the compound runs a bit slower than others due to the heavy substituents but still moves cleanly enough on silica gel for even mid-scale preps.
Folks who have built molecules for pharmaceutical research or custom synthesis quickly recognize the shape of this molecule. It frequently shows up where there’s a need for a reactive halide and an electron-withdrawing group to temper a pyrimidine core. In my experience, drug discovery teams appreciate substitutions at these positions—introducing both the bromo and trifluoromethyl arms lets medicinal chemists adjust pharmacokinetics and binding profiles. This dual activation (both electronic and steric tweaks) serves as a lever in lead optimization, and I’ve watched it contribute to developing kinase inhibitors or antiviral agents.
In agrochemical synthesis, the compound’s particular arrangement creates new routes for pyrimidine-based herbicides or pest control agents. Colleagues in crop science steer towards these molecules for both preclinical and field research phases, mostly because selective reactivity leads to clean follow-up substitutions and diversification. Whether it’s about attaching new fragments, adjusting for metabolic stability, or just blocking off certain ring positions, 5-Bromo-2-(Trifluoromethyl)Pyrimidine saves steps.
Sometimes, this compound emerges as an intermediate—never listed in a final patent, never highlighted, yet absolutely crucial. Organic chemists value these “problem solvers”: accessible, amenable to a range of transformations, and less fussy about reaction conditions than many close analogs. I’ve pushed this particular pyrimidine through copper-mediated couplings and even some less-tidy radical processes, neither requiring dry boxes nor ultra-pure solvents. R&D groups consistently mention reliable yields, good selectivity, and low levels of side-product formation. Such reliability takes weight off scale-up teams and supports regulatory teams in quality assurance.
Many bromopyrimidines show up in technical catalogs, but few combine a halide and trifluoromethyl quite like this. I’ve run substituent effect studies across plenty of heterocycles, and the combo here feels tailored for versatility. The trifluoromethyl group brings more metabolic resistance and changes the electronic profile. In drug-like molecules, adding fluorine atoms often leads to better oral bioavailability and ‘softer’ metabolic breakdown in vivo. Where plain 5-bromopyrimidines give you one kind of reactivity, adding that CF3 can really swing a reaction’s outcome and the compound’s later biological profile.
Compare this to 2-chloro or 2-methyl analogs, and there’s a world of difference. The 2-chloro-5-bromopyrimidine shows more reactivity toward nucleophilic displacement, leading to some messier outcomes. When you plug in the trifluoromethyl group at the 2-position, things slow down a touch where you want them to—and with catalysis or fine-tuned reaction conditions, that extra control matters. Unlike 2-methyl variations, which don’t offer the same electron-withdrawing pull, the CF3 delivers a big change in hydrogen-bonding and polarity.
Going further, other isomers or disubstituted pyrimidines often miss the synthetic “sweet spot” that pharmaceutical researchers hunt for. The combined steric and electronic influences of the bromine and trifluoromethyl groups at these positions shift rates and regioselectivities in precisely the way medicinal chemists need. Having worked with hundreds of analogs, I’ve found this particular layout to resolve issues in cross-coupling, especially when other routes kept delivering too much byproduct.
Few things stall progress in a research setting like a stubborn, difficult-to-handle intermediate. Over the years, I’ve appreciated chemicals that store easily, showing little sensitivity or degradation over months. 5-Bromo-2-(Trifluoromethyl)Pyrimidine performs well in this regard. Closed bottles on a typical lab shelf suffice; there’s seldom a reason for refrigeration or desiccation unless fine analytical grades are in play. Stability benefits teams juggling multiple parallel syntheses or needing stock solutions for screening.
Like most brominated aromatics, you take basic precautions: gloves, goggles, a working hood. Toxicity hasn’t cropped up as a regular concern in my runs, but it pays to treat all low-molecular-weight heterocycles cautiously. The low volatility keeps inhalation risks low during normal use, and accidental contact rarely leads to immediate side effects. With fluorinated organics, incineration and disposal should always stay within permitted routes; mixing with strong reducing agents or heated metals sometimes brings unpredictable results, as with many halogenated compounds. My teams routinely include this compound in safety assessments with few red flags relative to less stable or more volatile intermediates.
In research, every new intermediate either speeds up or slows down the process. Having used 5-Bromo-2-(Trifluoromethyl)Pyrimidine in several synthetic routes, I’ve noticed how it cuts down the number of steps to reach certain key frameworks. For large research organizations, or even start-ups working on their first promising targets, this translates to better use of time and budget. When lead optimization demands multiple rounds of analog creation, anything that provides consistent, high-conversion steps without costly purification merits a spot in the workflow.
One of the hidden strengths lies in the way this pyrimidine supports late-stage diversification. Medicinal chemists don’t always know which modifications customers (or regulators) will ask for next. With this building block sitting in inventory, teams can adjust substituents at just the right moment in the campaign. That flexibility helps keep research timelines on track, feeding directly into patent positions and IP strategies. Teams have shared cases where unexpected reactivity—driven by the compound’s unique substitution pattern—rescued stalled campaigns and generated new patentable space.
In agrochemistry, that same flexibility applies. Formulation scientists lean on intermediates able to undergo rapid, controlled substitutions, especially when plant or soil testing reveals a need for specific metabolic traits. By enabling these last-minute customizations, 5-Bromo-2-(Trifluoromethyl)Pyrimidine continues to earn a spot among the more dependable tools in the chemical kit.
The rise of fluorinated building blocks in commercial and academic labs has brought new questions about environmental impact. As a product that contains both bromine and a trifluoromethyl group, 5-Bromo-2-(Trifluoromethyl)Pyrimidine deserves scrutiny, particularly downstream. The chemical is neither a byproduct nor a final persistent pollutant when handled by the book, but waste disposal practices must stay current and compliant. Having spent years in labs with tight oversight, I’ve followed procedures where any halogenated waste funnels through dedicated collection; incineration happens with regulatory approval, tracking, and emissions checks.
Regulators worldwide continue updating guidelines for all fluorinated and halogenated organics. Compliance demands careful labeling, documentation, and disposal records—not only for hazard mitigation, but for broader environmental stewardship. In my experience, suppliers who track these trends keep researchers informed, distributing up-to-date certificates of analysis and guidance on use and waste. For development organizations, those habits lower risks and, just as important, build trust with oversight agencies.
Safety data informs not just day-to-day handling but risk management plans at organizational levels. Labs specifying 5-Bromo-2-(Trifluoromethyl)Pyrimidine as a regular intermediate seldom find red flags in environmental health reports, assuming protocols align with existing halogenated waste standards. Still, the presence of trifluoromethyl groups across the wider chemicals market has opened wider debates on environmental persistence, motivating ongoing improvements to synthetic and disposal approaches.
Having worked in synthesis-driven environments, I’ve seen how often “go-to” intermediates change as teams tackle new challenges. What impresses me about 5-Bromo-2-(Trifluoromethyl)Pyrimidine, year after year, is how it fits into both routine and cutting-edge projects. It’s not just about following a recipe or rubber-stamping a method; it’s about having a flexible, trustworthy building block for real progress. Several times, project deadlines pressed, and upstream issues forced creative thinking—tweaking reaction conditions, scavenging for collective experience. The reliability and versatility of this pyrimidine brought projects back on track, helped hit critical timelines, and constructed molecular libraries without the usual detours from side reactions or stubborn purifications.
Academic labs, start-up research groups, and big pharma each look for efficiency in their intermediates. Products like this one don’t always grab headlines or marketing budgets, but on the ground, chemists tell their own story about what solves practical problems. I remember reaching for this exact compound during an exploratory synthesis screen that needed both high reactivity and the option for post-installation modification. None of the close relatives offered that blend of selectivity and manageability.
This reality—the value built from many small, everyday wins—explains why experienced scientists include compounds like 5-Bromo-2-(Trifluoromethyl)Pyrimidine in their core inventories. Talking with colleagues in both pharma and agricultural firms, there’s common ground around reliability, cost-effectiveness, and adaptability. The trifluoromethyl group confers both chemical stability and pharmacological draw; the strategically placed bromine opens a range of cross-coupling and nucleophilic substitution possibilities. These are not just academic points: in scaling up for production or validating a library, time spent on reliable transformations means time not lost to bottlenecks elsewhere.
Looking at trends in fine chemical development, the appreciation for well-designed intermediates only grows. Organizations track new regulatory concerns, look for greener methods, and keep pushing the boundaries of molecular complexity. Yet, there’s still a place for intermediates that “just work”—that fit smoothly into established as well as experimental workflows. 5-Bromo-2-(Trifluoromethyl)Pyrimidine keeps that place, and based on ongoing conversations with research leaders, it’s not in danger of losing it anytime soon.
No compound is without its downsides. The presence of both bromine and a trifluoromethyl group raises flags for those worried about long-term environmental persistence. Responsible practitioners recognize this, pushing suppliers and contract manufacturers to publish full life-cycle data and look for cleaner synthetic routes. Several groups have begun collaborating on strategies to recover and recycle halogenated waste, turning what used to be a disposal challenge into resources for new synthesis.
Innovation comes both from green chemistry advancements and from process design that limits unnecessary use. Researchers working in flow chemistry, for example, have started integrating 5-Bromo-2-(Trifluoromethyl)Pyrimidine into continuous processes, reducing batch waste and improving containment. I’ve witnessed incremental improvements: fewer hazardous byproducts, better capture of solvents, and routes that use less aggressive conditions without compromising yield. These improvements stack up over hundreds or thousands of runs, creating a meaningful reduction in overall environmental and health impact.
Companies supplying the chemical increasingly certify their supply chains—documenting source materials, energy use, and emissions, sometimes with third-party audits for transparency. As environmental, health, and safety teams become more proactive, the real winners are researchers who don’t just “get the job done” but handle their intermediates with care. I see this as the direction the industry must take: combining chemical innovation with responsibility. For those choosing among intermediates, transparent declarations and support for greener chemistry guide better decisions.
Selecting intermediates is rarely about chasing a single best solution; it’s more about finding what actually delivers where it counts. 5-Bromo-2-(Trifluoromethyl)Pyrimidine hits the mark through dependability, reactivity, and adaptability—not through flash but through what it brings to the working scientist. From my experience, it makes short work of difficult couplings, stays pure under real-world conditions, and pushes projects forward on practical timelines. Scientists drawn to the field by curiosity and challenge value this kind of tool—one that fits seamlessly into today’s projects and tomorrow’s breakthroughs.
Direct contact with the field, ongoing conversations with synthetic and development chemists, and hands-on troubleshooting all point to this pyrimidine playing an outsized role compared to its price or catalog presence. The important questions now turn to making the most of its advantages: ensuring it’s used responsibly, integrated with greener technologies, and supported by open information sharing. Commitment to quality, safety, and sustainability secures the product’s standing—and ensures it keeps earning the trust and confidence of those counting on it for real scientific progress.
In my day-to-day work, and through connections built with colleagues across continents and sectors, I see how compounds like this quietly shape the discoveries that move industries forward. Achievements rarely rest on flash or hype. Instead, the backbone often reflects products that work the way they’re supposed to and keep earning their place by solving real problems under the most demanding conditions.